Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,950,000 | 5,282,000 | 7,268,000 | 9,791,900 | 3,375,900 |
| Marketable Securities | N/A | N/A | N/A | 121,600 | 170,100 |
| Receivables | 23,475,000 | 21,177,000 | 20,155,000 | 19,457,200 | 17,205,600 |
| Inventories | 16,793,000 | 14,529,000 | 13,744,000 | 12,180,400 | 11,013,800 |
| Other current assets | 86,000 | 214,000 | 147,000 | 271,500 | 68,800 |
| TOTAL | $64,672,000 | $54,835,000 | $55,629,000 | $62,071,300 | $49,854,000 |
| Non-Current Assets | |||||
| PPE Net | 29,286,000 | 26,540,000 | 24,675,000 | 22,316,000 | 20,529,700 |
| Investments And Advances | 3,856,000 | 3,116,000 | 2,802,000 | 2,808,300 | 3,207,400 |
| Intangibles | 18,110,000 | 7,374,000 | 6,521,000 | 6,446,700 | 5,908,300 |
| Other Non-Current Assets | 26,359,000 | 24,711,000 | 22,849,000 | 21,293,100 | 21,423,200 |
| TOTAL | $77,611,000 | $61,741,000 | $56,847,000 | $52,864,100 | $51,068,600 |
| Total Assets | $142,283,000 | $116,576,000 | $112,476,000 | $114,935,400 | $100,922,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,050,000 | N/A | 1,635,000 | N/A | 5,723,700 |
| Accounts payable and accrued liabilities | 6,112,000 | 5,029,000 | 5,379,000 | 4,262,200 | 4,075,700 |
| Other current liabilities | 34,579,000 | 27,605,000 | 28,214,000 | 24,801,300 | 20,917,300 |
| TOTAL | $47,741,000 | $36,634,000 | $35,228,000 | $40,140,900 | $39,019,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,858,000 | 39,370,000 | 40,868,000 | 40,873,600 | 34,180,100 |
| Other Non-Current Liabilities | 12,805,000 | 9,374,000 | 9,845,000 | 10,070,100 | 9,373,500 |
| TOTAL | $60,663,000 | $48,744,000 | $50,713,000 | $50,943,700 | $43,553,600 |
| Total Liabilities | $108,404,000 | $85,378,000 | $85,941,000 | $91,084,600 | $82,573,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 941,357 | 941,741 | 943,357 | 945,384 | 946,457 |
| Common Shares | 588,000 | 590,000 | 590,000 | 591,400 | 592,000 |
| Retained earnings | 31,893,000 | 29,514,000 | 24,470,000 | 22,252,000 | 17,376,200 |
| Other shareholders' equity | -5,719,000 | -5,827,000 | -5,871,000 | -6,161,500 | -6,653,400 |
| TOTAL | $33,879,000 | $31,198,000 | $26,535,000 | $23,850,800 | $18,349,100 |
| Total Liabilities And Equity | $142,283,000 | $116,576,000 | $112,476,000 | $114,935,400 | $100,922,600 |